Evidence map›Paper›PMID 42734431›Full record

ArticleAmerican journal of physiology. Renal physiology2026

Impact of renal iron overload on sickle cell nephropathy in a humanized mouse model.

Mohammad O Sako, Bryant J Kane, Michael Booze, Savannah Walker, Margi Patel, Sirisha Swamigari, Hung Nguyen, Kelly A Hyndman, Tanecia Mitchell, Subhashini Bolisetty and 1 more

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad O SakoDivision of Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Bryant J KaneDivision of Hematology, Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Michael BoozeDivision of Hematology, Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Savannah WalkerDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Margi PatelDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Sirisha SwamigariDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Hung NguyenDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0009-0006-8659-7080
Kelly A HyndmanDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0002-8465-2588
Tanecia MitchellDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0002-4032-913X
Subhashini BolisettyDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0002-4650-3151
Malgorzata KasztanDivision of Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0003-3345-1580

Funding

TRIO NRSA Training CoreTL1DK139567 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Graca Duarte Almeida-Porada, Steven D Crowley · 2023 to 2026
$3.3M
Oxalate-Driven Host Responses in Kidney Stone DiseaseR01DK129885 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Tanecia R Mitchell · 2022 to 2026
$2.7M
Functional Significance of Ferritin Light Chain in Sepsis-associated Kidney InjuryR01DK122986 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOLISETTY, SUBHASHINI · 2021 to 2025
$1.7M
Epigenetic Regulation of Kidney Fibrosis following AKIR01DK126664 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HYNDMAN, KELLY · 2021 to 2024
$1.7M
Endothelin 1 in iron handling in sickle cell diseaseR01HL173038 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Malgorzata Kasztan · 2025 to 2026
$1.1M
American Society of Nephrology (ASN) Norman Siegel Research Scholar GrantHHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL173038HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK122986HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK126664HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK129885HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) TL1DK139567NHLBI NIH HHS R01 HL173038NIDDK NIH HHS R01 DK122986NIDDK NIH HHS R01 DK126664NIDDK NIH HHS R01 DK129885NIDDK NIH HHS TL1 DK139567
6 · The paper itself

Abstract

Increased morbidity and mortality are associated with iron overload in sickle cell disease (SCD). Renal iron accumulation, a direct consequence of intravascular hemolysis, occurs in both patients and murine model of SCD, and correlates with albuminuria, an early marker of kidney injury. We aimed to investigate the role of kidney-specific iron accumulation and underlying mechanisms contributing to iron overload-mediated SCD nephropathy in humanized sickle cell disease (HbSS) mice. In addition, as sex differences in renal phenotype exist, we examined sex disparities in iron-associated toxicity in murine SCD. Iron chelation significantly reduced renal iron accumulation and subsequently prevented a decline in kidney function and disease progression only in male HbSS mice. Examining the mechanisms of kidney injury, secondary to renal iron accumulation, revealed the presence of oxidative stress and concurrent absence of ferroptosis in HbSS mice. In addition, the proximal tubule from HbSS male mice had reduced basal mitochondrial respiration compared with HbSS female mice. Iron chelation had no effect on any of the tested injury-mediated pathways but did reduce proinflammatory signature in the kidneys of HbSS mice. These results demonstrate that iron chelation exerts nephroprotective effects in male HbSS mice, whereas enhanced mitochondrial quality in HbSS female may account, at least in part, for potential sex differences in SCD nephropathy.

Indexed as

Anemia, Sickle CellIronIron OverloadKidneyKidney DiseasesAnimalsDisease Models, AnimalFemaleFerroptosisHumansIron Chelating AgentsMaleMiceMice, TransgenicMitochondriaOxidative StressIronIron Chelating Agentsferroptosisiron chelationmitochondrial dysfunctionoxidative stresssickle cell nephropathy

Identifiers

PMID42734431
PMCPMC13639985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.